Current and novel device-led approaches for targeted obstructive sleep apnea screening, diagnosis, treatment, and...

Obstructive sleep apnea (OSA) is a prevalent sleep disorder associated with serious health consequences and major economic burdens. Current diagnosis and treatment approaches are insufficient for the growing global burden of OSA. Novel device-led technologies may enable more efficient and personalized OSA management.

This review explores the potential role of screening tools such as regulatory-cleared wearables and discusses recent advancements in simplified home sleep testing and automated scoring software. Current and emerging OSA treatment monitoring systems, treatment optimization approaches, and therapy guidance tools are explored. Finally, we highlight the role of cloud-based platforms, telehealth, and AI-driven applications in enabling long-term monitoring and precision medicine approaches.

Novel OSA-related devices are enhancing clinical practice by improving access, adherence, and therapy outcomes. Patients and clinicians are encouraged to embrace the technology with caution. Challenges remain in the accuracy of diagnostic and treatment devices, ensuring data privacy, and integrating these tools into clinical practice. Regulatory bodies must advocate for independent clinical trial validation standards, algorithmic transparency, and education on novel devices for patients and clinicians, to ensure safe implementation. With continued innovation, validation, and adoption, device-led care may become central to the proactive and patient-centered future of OSA management.